Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Florida Orthopaedic Institute
mi
from
Tampa, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Florida Orthopaedic Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
FMC Orthopedic Division
mi
from
Tampa, FL
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
FMC Orthopedic Division
mi
from
Tampa, FL
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Resurgens Orthopaedics
mi
from
Austell, GA
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Resurgens Orthopaedics
mi
from
Austell, GA
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
OrthoCarolina Hip & Knee Center
mi
from
Charlotte, NC
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
OrthoCarolina Hip & Knee Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Memorial Bone & Joint
mi
from
Houston, TX
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Memorial Bone & Joint
mi
from
Houston, TX
Click here to add this to my saved trials
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated:  12/31/1969
Elective Orthopaedic Centre
mi
from
Epsom,
Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Status: Enrolling
Updated: 12/31/1969
Elective Orthopaedic Centre
mi
from
Epsom,
Click here to add this to my saved trials
Topical Tranexamic Acid (TXA) in Joint Arthroplasty
Topical Application of Tranexamic Acid in Joint Arthroplasty
Status: Enrolling
Updated:  12/31/1969
Steadman Hawkins Clinic of the Carolinas - Greenville Health System
mi
from
Greenville, SC
Topical Tranexamic Acid (TXA) in Joint Arthroplasty
Topical Application of Tranexamic Acid in Joint Arthroplasty
Status: Enrolling
Updated: 12/31/1969
Steadman Hawkins Clinic of the Carolinas - Greenville Health System
mi
from
Greenville, SC
Click here to add this to my saved trials
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging
Status: Enrolling
Updated:  12/31/1969
AARDS Research, Inc
mi
from
Aventura, FL
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging
Status: Enrolling
Updated: 12/31/1969
AARDS Research, Inc
mi
from
Aventura, FL
Click here to add this to my saved trials
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
Clinical Intervention Study: Adverse Events and Clinical Outcomes for the Deployment of Adipose Derived SVF (Rich in Adult Stem Cells and Growth Factors)for Select Orthopedic, Neurologic, Urologic, and Cardio-Pulmonary Conditions.
Status: Enrolling
Updated:  12/31/1969
California Stem Cell Treatment Center
mi
from
Rancho Mirage, CA
Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions
Clinical Intervention Study: Adverse Events and Clinical Outcomes for the Deployment of Adipose Derived SVF (Rich in Adult Stem Cells and Growth Factors)for Select Orthopedic, Neurologic, Urologic, and Cardio-Pulmonary Conditions.
Status: Enrolling
Updated: 12/31/1969
California Stem Cell Treatment Center
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
Status: Enrolling
Updated:  12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Use of FlexHD as Post Trapeziectomy Spacer
Use of FlexHD as a Post-Trapeziectomy Spacer in Patients Treated for Thumb Basal Joint Arthritis
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Department of Hand Surgery
mi
from
Los Angeles, CA
Use of FlexHD as Post Trapeziectomy Spacer
Use of FlexHD as a Post-Trapeziectomy Spacer in Patients Treated for Thumb Basal Joint Arthritis
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Department of Hand Surgery
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Rheumatology Associates, PC
mi
from
Birmingham, AL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Rheumatology Associates, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Rheumatology Associates Of North Alabama, P.C.
mi
from
Huntsville, AL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Rheumatology Associates Of North Alabama, P.C.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare
mi
from
Fullerton, CA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare
mi
from
Fullerton, CA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Desert Medical Advances
mi
from
Palm Desert, CA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Desert Medical Advances
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
San Diego Arthritis Medical Clinic
mi
from
San Diego, CA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
San Diego Arthritis Medical Clinic
mi
from
San Diego, CA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Rheumatology Associates of Central Florida
mi
from
Orlando, FL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Rheumatology Associates of Central Florida
mi
from
Orlando, FL
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Millennium Research
mi
from
Ormond Beach, FL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Millennium Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Integral Rheumatology & Immunology Specialists (IRIS)
mi
from
Plantation, FL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Integral Rheumatology & Immunology Specialists (IRIS)
mi
from
Plantation, FL
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
St. Luke's Intermountain Research Center
mi
from
Boise, ID
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
St. Luke's Intermountain Research Center
mi
from
Boise, ID
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Bluegrass Community Research, Inc
mi
from
Lexington, KY
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Bluegrass Community Research, Inc
mi
from
Lexington, KY
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Klein & Associates MD, PA.
mi
from
Hagerstown, MD
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Klein & Associates MD, PA.
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
St. Paul Rheumatology, PA
mi
from
Eagan, MN
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
St. Paul Rheumatology, PA
mi
from
Eagan, MN
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Physician Research Collaboration
mi
from
Lincoln, NE
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Physician Research Collaboration
mi
from
Lincoln, NE
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Cincinnati Rheumatic Disease Study Group
mi
from
Cincinnati, OH
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Cincinnati Rheumatic Disease Study Group
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Paramount Medical Research & Consulting, Llc
mi
from
Middleburg Heights, OH
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Paramount Medical Research & Consulting, Llc
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
East Penn Rheumatology Associates, P.C.
mi
from
Bethlehem, PA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
East Penn Rheumatology Associates, P.C.
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
The Arthritis Clinic
mi
from
Jackson, TN
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
The Arthritis Clinic
mi
from
Jackson, TN
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
West Tennessee Research Institute
mi
from
Jackson, TN
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
West Tennessee Research Institute
mi
from
Jackson, TN
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
University of Utah Hospital and Clinics
mi
from
Salt Lake City, UT
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
University of Utah Hospital and Clinics
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Seattle Rheumatology Associates
mi
from
Seattle, WA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Seattle Rheumatology Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Florida Medical Clinic
mi
from
Zephyrhills, FL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Florida Medical Clinic
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Royal Prince Alfred Hospital
mi
from
Camperdown,
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Royal Prince Alfred Hospital
mi
from
Camperdown,
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Arizona Arthritis & Rheumatology Associates, PC
mi
from
Glendale, AZ
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Arizona Arthritis & Rheumatology Associates, PC
mi
from
Glendale, AZ
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Adriana Pop-Moody MD - Clinic PA
mi
from
Corpus Christi, TX
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Adriana Pop-Moody MD - Clinic PA
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
The Center for Rheumatology and Bone Research
mi
from
Wheaton, MD
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
The Center for Rheumatology and Bone Research
mi
from
Wheaton, MD
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Clayton Medical Research
mi
from
Saint Louis, MO
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Clayton Medical Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
St. Luke's Clinic - Rheumatology
mi
from
Boise, ID
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
St. Luke's Clinic - Rheumatology
mi
from
Boise, ID
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Investigational Drug Services
mi
from
Salt Lake City, UT
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Investigational Drug Services
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
New England Research Associates, LLC
mi
from
Bridgeport, CT
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
New England Research Associates, LLC
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Arthritis Center, Inc.
mi
from
Palm Harbour, FL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Arthritis Center, Inc.
mi
from
Palm Harbour, FL
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Pioneer Research Solutions
mi
from
Cypress, TX
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Pioneer Research Solutions
mi
from
Cypress, TX
Click here to add this to my saved trials
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated:  12/31/1969
Integral Rheumatology & Immunology Specialists
mi
from
Plantation, FL
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB (CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Status: Enrolling
Updated: 12/31/1969
Integral Rheumatology & Immunology Specialists
mi
from
Plantation, FL
Click here to add this to my saved trials